I agree that this site is using cookies. You can find further informations here.
X
Matsukawa, Miyuki
42  results:
Search for persons X
?
1

Initial eGFR Changes Predict Response to Tolvaptan in ADPKD:

Mochizuki, Toshio ; Matsukawa, Miyuki ; Tanaka, Toshiki.
Kidney360.  5 (2024)  4 - p. 522-528 , 2024
Link: https://doi.org/10.34067..
 
?
2

Quality of life and work productivity and activity impairme..:

Ishii, Ryotaro ; Sakai, Fumihiko ; Sano, Hiromi...
Frontiers in Neurology.  15 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
3

Timing of Worsening Renal Function in Patients Hospitalized..:

Shiraishi, Yasuyuki ; Kurita, Yuka ; Mori, Hiromasa..
Circulation Journal.  88 (2024)  5 - p. 680-691 , 2024
Link: https://doi.org/10.1253/..
 
?
4

Comparison of the treatment status of patients with acute h..:

Shibata, Tatsuhiro ; Matsumoto, Shingo ; Muramoto, Tomoki.
Journal of Cardiology.  84 (2024)  1 - p. 47-54 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Real-World Intravenous Diuretic Use to Treat Congestion in ..:

Shiraishi, Yasuyuki ; Kurita, Yuka ; Matsukawa, Miyuki.
Circulation Reports.  5 (2023)  2 - p. 27-37 , 2023
Link: https://doi.org/10.1253/..
 
?
6

Impact of tolvaptan add-on treatment on patients with heart..:

Kinugawa, Koichiro ; Matsukawa, Miyuki ; Nakamura, Yumiko..
Journal of Cardiology.  82 (2023)  1 - p. 35-42 , 2023
Link: https://doi.org/10.1016/..
 
?
7

A retrospective study on tolvaptan prescription in clinical..:

Hagiwara, Daisuke ; Matsukawa, Miyuki ; Tasaki, Junko..
Endocrine Journal.  70 (2023)  12 - p. 1195-1205 , 2023
Link: https://doi.org/10.1507/..
 
?
8

Treatment Discontinuation Among Patients with Schizophrenia..:

Hishimoto, Akitoyo ; Yasui-Furukori, Norio ; Sekine, Daisuke..
Advances in Therapy.  39 (2022)  9 - p. 4299-4314 , 2022
Link: https://doi.org/10.1007/..
 
?
9

Real-world Safety and Effectiveness of Infliximab in Pediat..:

Miura, Masaru ; Kobayashi, Tohru ; Igarashi, Toru...
Pediatric Infectious Disease Journal.  39 (2020)  1 - p. 41-47 , 2020
Link: https://doi.org/10.1097/..
 
?
10

Long-Term, Real-World Safety and Efficacy of Teneligliptin:..:

Kadowaki, Takashi ; Haneda, Masakazu ; Ito, Hiroshi...
Advances in Therapy.  37 (2019)  3 - p. 1065-1086 , 2019
Link: https://doi.org/10.1007/..
 
?
11

Safety and efficacy of infliximab in the treatment of refra..:

Ohno, Shigeaki ; Umebayashi, Itsuro ; Matsukawa, Miyuki..
Arthritis Research & Therapy.  21 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
12

Associations between eating habits and glycemic control and..:

Gouda, Maki ; Matsukawa, Miyuki ; Iijima, Hiroaki
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.  11 (2018)  - p. 647-658 , 2018
Link: https://doi.org/10.2147/..
 
?
13

Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabet..:

Kadowaki, Takashi ; Sasaki, Kazuyo ; Ishii, Manabu..
Diabetes Therapy.  9 (2018)  2 - p. 623-636 , 2018
Link: https://doi.org/10.1007/..
 
?
14

Relationship of Eating Patterns and Metabolic Parameters, a..:

Kadowaki, Takashi ; Haneda, Masakazu ; Ito, Hiroshi...
Advances in Therapy.  35 (2018)  6 - p. 817-831 , 2018
Link: https://doi.org/10.1007/..
 
?
15

Safety profiles and efficacy of infliximab therapy in Japan..:

Torii, Hideshi ; Terui, Tadashi ; Matsukawa, Miyuki...
The Journal of Dermatology.  43 (2015)  7 - p. 767-778 , 2015
Link: https://doi.org/10.1111/..
 
1-15